CME Group Inc. Files 8-K on Financials
Ticker: CME · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1156375
| Field | Detail |
|---|---|
| Company | Cme Group Inc. (CME) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: CME
TL;DR
CME Group dropped an 8-K on 10/22/25 covering financials. Check it out.
AI Summary
CME Group Inc. filed an 8-K on October 22, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing pertains to the period ending October 22, 2025. CME Group Inc., incorporated in Delaware, is headquartered at 20 S. Wacker Drive, Chicago, IL.
Why It Matters
This 8-K filing provides investors with updated information on CME Group's financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant events.
Key Players & Entities
- CME Group Inc. (company) — Registrant
- October 22, 2025 (date) — Date of report
- 20 South Wacker Drive, Chicago, Illinois 60606 (address) — Principal Executive Office
- Delaware (jurisdiction) — State of Incorporation
- 001-31553 (filing_id) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on CME Group Inc.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is October 22, 2025.
Where is CME Group Inc. headquartered?
CME Group Inc. is headquartered at 20 South Wacker Drive, Chicago, Illinois 60606.
In which state is CME Group Inc. incorporated?
CME Group Inc. is incorporated in Delaware.
What is the SEC file number for CME Group Inc.?
The SEC file number for CME Group Inc. is 001-31553.
Filing Stats: 678 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2025-10-22 07:05:05
Filing Documents
- cme-20251022.htm (8-K) — 35KB
- exhibit9919302025.htm (EX-99.1) — 277KB
- approvedpressreleasetempla.jpg (GRAPHIC) — 61KB
- 0001156375-25-000204.txt ( ) — 529KB
- cme-20251022.xsd (EX-101.SCH) — 2KB
- cme-20251022_lab.xml (EX-101.LAB) — 21KB
- cme-20251022_pre.xml (EX-101.PRE) — 12KB
- cme-20251022_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. The information set forth under "Item 2.02. Results Of Operations and Financial Condition," including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of CME Group Inc. dated October 22, 2025, reporting CME Group Inc.'s financial results for the quarter ended September 30, 2025. To supplement CME Group's financial statements on a GAAP basis, the attached press release includes financial measures that are not in accordance with GAAP, consisting of non-GAAP revenues, expenses, operating income, net income and earnings per share. Management believes that the presentation of non-GAAP revenues, expenses, operating income, net income and earnings per share provide important supplemental information to management and investors about financial and business trends relating to CME Group Inc.'s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provide a better measure of comparability with the Company's prior financial reports. Management acknowledges that non-GAAP adjustments may include recurring items. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Pursuant to the requirements of Regulation G, CME Group Inc. has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in the press release.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release, dated October 22 , 2025. 104 The cover page from CME Group Inc.'s Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CME Group Inc. Registrant Date: October 22, 2025 By: /s/ Lynne Fitzpatrick Name: Title: Lynne Fitzpatrick Senior Managing Director, President and Chief Financial Officer Principal Financial Offer and Duly Authorized Officer